Only logged-in users can see full content details
ZAGREB, April 7
(Hina) - Croatia's Agency for Medicinal Products and
Medical Devices (HALMED) has granted a request of the Institute of
Immunology (IMZ) to postpone a scrutiny review of the Institute that
was to have been conducted April 7 - 9 to define whether the Institute
had removed shortcomings that represent a risk to public health.